CPRXCatalyst Pharmaceuticals, Inc.

31.49USD0.00%Mkt Cap: 3.85B $P/E: 18.20

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the tr…

Key Statistics

Company
Market Cap3.85B $
Enterprise Value3.10B $
Revenue (TTM)596.96M $
Gross Profit501.74M $
Net Income (TTM)214.33M $
Revenue/Share4.874 USD
Last Price31.49 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees182
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS14888U1016
Valuation
P/E (Trailing)18.20
P/E (Forward)9.90
PEG
EV/EBITDA10.14
EV/Revenue5.19
P/S6.46
P/B3.80
EPS (TTM)1.73
EPS (Forward)3.48
52W Range
19.0592% of range32.56
52W High32.56 USD
52W Low19.05 USD
Profitability
Gross Margin85.19%
Oper. Margin49.02%
EBITDA Margin51.23%
Profit Margin36.39%
ROE22.46%
ROA19.41%
Growth
Revenue Growth5.60%
Earnings Growth11.10%
Cash Flow & Leverage
Operating CF208.67M $
CapEx (TTM)58.00K $
FCF Margin28.78%
FCF Yield4.46%
Net Debt-753.18M $
Net Debt/EBITDA-2.46
Balance Sheet
Debt/Equity0.00
Current Ratio7.10
Quick Ratio6.70
Book Value/Sh8.288 USD
Cash/Share6.176 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)31.67 USD
Upside (mean)+0.6%
Target Range31.50 USD32.00 USD
$31.50+0.6% to mean$32.00
# Analysts3
Ownership
Shares Out.122.42M
Float115.58M
Insiders5.57%
Institutions90.00%
Short Interest
Short Ratio4.1d
Short % Float6.78%
Short % Out.6.41%
Shares Short7.85M
Short (prev mo.)8.19M
Technical
SMA 5031.37 (+0.4%)
SMA 20025.90 (+21.6%)
Beta0.74
S&P 52W Chg18.16%
Avg Vol (30d)1.74M
Avg Vol (10d)2.60M
Technical Indicators
RSI (14)70.2
MACD0.1326
MACD Signal0.1779
MACD Hist.-0.0453
BB Upper31.54 USD
BB Middle31.46 USD
BB Lower31.38 USD
BB Width0.51%
ATR (14)0.0596 USD
Vol Ratio (20d)0.00x